Product deatails
Comprehensive cancer profiling provides informed treatment decisions for different types of cancer.
Cancer+ Discovery Panel is one of the market’s most comprehensive and accurate NGS based testing solutions for the identification of clinically actionable mutations and the discovery of novel variants with important functions in cancer. Supporting both tissue sample and liquid biopsy, the panel offers whole exome coverage of 816 cancer-related genes across all solid tumor types and interrogates the most common types of alterations, including SNVs, indels, CNVs and fusions in solid tumors.
Share with us:
With Leukemia gene detection (DNA+RNA / DNA) panels, 373 / 183 leukemia-related genes associated with hematologic malignancies can be studied by simultaneously analyzing DNA and RNA from blood samples in a single assay. The panels cover relevant targets for the following major myeloid and lymphoid disorders: acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL) and chronic myeloid leukemia (CML).
Cancer Medication Guidance can provide informed treatment decisions for non-small cell lung (50/20/13 genes), colorectal (23 genes), gastric (20 genes) and gastrointestinal (20 genes) cancer patients and identify treatment options or clinical trials for patients before starting first-line therapy or during the disease progression.